ALISAH II: A proposed clinical trial

Preview:

Citation preview

ALISAH II

A Phase III Clinical Trial

ALISAH II

A Phase III Clinical Trial

90 day GOS

2ry

72 h

25 %

1.25 g/kg/d

7 days

Who?

18 - 80

WFNS1 - 3

Claassen2 - 4

SaccularAneurysm

EF < 40%

Cr > 177

COPD

LiverFailure

Pregnant

1250 pts

85 sites

4747

66

44

77

88

1313

3 years

$8420

01.06.12

Recommended